Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 4, pp. 589-596
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Yujun Tang, Jiajia Liu, Dingyi Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 1023
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Thibault Fiolet, Anthony Guihur, Mathieu E. Rebeaud, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 19-27
Open Access | Times Cited: 295
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up
Amir Tajbakhsh, Seyed Mohammad Gheibi Hayat, Hajar Taghizadeh, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 3, pp. 345-357
Closed Access | Times Cited: 242
Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective
Awadhesh Kumar Singh, Sujoy Majumdar, Ritu Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 5, pp. 971-978
Open Access | Times Cited: 228
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
Olayinka O. Ogunleye, Debashis Basu, Debjani Mueller, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 191
COVID-19 Digital Health Innovation Policy: A Portal to Alternative Futures in the Making
Mustafa Bayram, Simon Springer, Colin Garvey, et al.
OMICS A Journal of Integrative Biology (2020) Vol. 24, Iss. 8, pp. 460-469
Closed Access | Times Cited: 78
Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review
Claudio Tirelli, Mara De Amici, Cristina Albrici, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 177-177
Open Access | Times Cited: 29
Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection
Anchalee Prasansuklab, Atsadang Theerasri, Panthakarn Rangsinth, et al.
Journal of Traditional and Complementary Medicine (2020) Vol. 11, Iss. 2, pp. 144-157
Open Access | Times Cited: 66
Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
Abdullahi Rabiu Abubakar, Ibrahim Sani, Brian Godman, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 4673-4695
Open Access | Times Cited: 61
Taming the Autophagy as a Strategy for Treating COVID-19
Blanca Estela García‐Pérez, Juan Antonio González-Rojas, Ma Isabel Salazar, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2679-2679
Open Access | Times Cited: 57
No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials”
Dr Subodh Kumar Pathak, Dr Abhijeet Ashok Salunke, Praveen Thivari, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 1673-1680
Open Access | Times Cited: 51
Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study
Chris A. Gentry, Mary Beth Humphrey, Sharanjeet K. Thind, et al.
The Lancet Rheumatology (2020) Vol. 2, Iss. 11, pp. e689-e697
Open Access | Times Cited: 40
The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: A Review
Felix Scholkmann, Tanja Restin, Marco Ferrari, et al.
Journal of Clinical Medicine (2020) Vol. 10, Iss. 1, pp. 50-50
Open Access | Times Cited: 40
Virus, Exosome, and MicroRNA: New Insights into Autophagy
Javid Sadri Nahand, Arash Salmaninejad, Samaneh Mollazadeh, et al.
Advances in experimental medicine and biology (2022), pp. 97-162
Closed Access | Times Cited: 22
A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19
Surojit Banerjee, Debadri Banerjee, Anupama Singh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 332-332
Open Access | Times Cited: 11
Current treatment protocol for COVID-19 in India
Surbhi Sharma, Soumen Basu, Nagaraj P. Shetti, et al.
Sensors International (2020) Vol. 1, pp. 100013-100013
Open Access | Times Cited: 31
Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis
Jogender Kumar, Siddharth Jain, Jitendra Meena, et al.
Journal of Infection and Chemotherapy (2021) Vol. 27, Iss. 6, pp. 882-889
Open Access | Times Cited: 24
Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis
Tawanda Chivese, Omran A. H. Musa, George Hindy, et al.
Travel Medicine and Infectious Disease (2021) Vol. 43, pp. 102135-102135
Open Access | Times Cited: 24
Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.
Paul Eze, Kenechukwu Mezue, Chidozie Nduka, et al.
PubMed (2021) Vol. 11, Iss. 1, pp. 93-107
Closed Access | Times Cited: 23
Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews
Massimo Franchini, F Corsini, Daniele Focosi, et al.
Diagnostics (2021) Vol. 11, Iss. 9, pp. 1663-1663
Open Access | Times Cited: 23
Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients
Tzu-Han Yang, Chian-Ying Chou, Yifan Yang, et al.
Journal of the Chinese Medical Association (2020) Vol. 84, Iss. 2, pp. 233-241
Open Access | Times Cited: 26
Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials
Young Joo Han, Keum Hwa Lee, Sojung Yoon, et al.
Theranostics (2020) Vol. 11, Iss. 3, pp. 1207-1231
Open Access | Times Cited: 26
The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis
Teshale Ayele Mega, Temesgen Mulugeta, Dula Dessalegn Bosho, et al.
Canadian Respiratory Journal (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 25
Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics
Hyung Muk Choi, Soo Youn Moon, Hyung In Yang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1737-1737
Open Access | Times Cited: 22
Evidence of the presence of SARS‐CoV‐2 virus in atmospheric air and surfaces of a dedicated COVID hospital
Abhishek Dubey, Garima Kotnala, T. K. Mandal, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 9, pp. 5339-5349
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top